IMS
CLVS

Index Management Solutions’s Clovis Oncology, Inc. CLVS Stock Holding History

Index Management Solutions’s Portfolio CLVS Stock Details CLVS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q3 		$5K Buy
+53
New +$4.59K 0.01% 627

Other funds holding CLVS

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
PAI
Palo Alto Investors Palo Alto, California $654M AUM 77.8% 1-Year Est. Return
PHS
PFM Health Sciences San Francisco, California $1.1B AUM 57.92% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
O
OppenheimerFunds New York $80.4B AUM 15.1% 1-Year Est. Return
AA
Antipodean Advisors New York $19.5M AUM 6.21% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
NMC
NEA Management Company Timonium, Maryland $1.76B AUM 223.33% 1-Year Est. Return
O
OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return

Index Management Solutions's CLVS Position: Q3 2015 in Review

Index Management Solutions opened a new position in Clovis Oncology, Inc. (CLVS) in Q3 2015: 53 shares worth $5K. The stake represents 0.01% of the portfolio and ranks #627 among its holdings.

192 funds tracked by Wall St. Rank hold CLVS as of Q3 2015.

  • Index Management Solutions held 53 shares of Clovis Oncology, Inc. worth $5K as of Q3 2015.
  • Clovis Oncology, Inc. was a new Index Management Solutions position in Q3 2015.
  • Clovis Oncology, Inc. made up 0.01% of Index Management Solutions's portfolio in Q3 2015, its #627 holding.
  • 192 funds tracked by Wall St. Rank held Clovis Oncology, Inc. as of Q3 2015.

Based on Index Management Solutions's 13F filing for Q3 2015, filed 13 Nov 2015.